Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease

Hein, 2003, Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms, Circulation, 107, 984, 10.1161/01.CIR.0000051865.66123.B7

Krayenbuehl, 1989, Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement, Circulation, 79, 744, 10.1161/01.CIR.79.4.744

Maron, 1975, Myocardial ultrastructure in patients with chronic aortic valve disease, Am J Cardiol, 35, 725, 10.1016/0002-9149(75)90065-X

Schwarz, 1978, Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results, Am J Cardiol, 41, 661, 10.1016/0002-9149(78)90814-7

Heymans, 2005, Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart, Circulation, 112, 1136, 10.1161/CIRCULATIONAHA.104.516963

Villari, 1995, Normalization of diastolic dysfunction in aortic stenosis late after valve replacement, Circulation, 91, 2353, 10.1161/01.CIR.91.9.2353

Kim, 2000, The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med, 343, 1445, 10.1056/NEJM200011163432003

Simonetti, 2001, An improved MR imaging technique for the visualization of myocardial infarction, Radiology, 218, 215, 10.1148/radiology.218.1.r01ja50215

Wagner, 2003, Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study, Lancet, 361, 374, 10.1016/S0140-6736(03)12389-6

Wu, 2001, Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction, Lancet, 357, 21, 10.1016/S0140-6736(00)03567-4

Mahrholdt, 2005, Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies, Eur Heart J, 26, 1461, 10.1093/eurheartj/ehi258

Moon, 2004, The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy, J Am Coll Cardiol, 43, 2260, 10.1016/j.jacc.2004.03.035

Rochitte, 2005, Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity, J Am Coll Cardiol, 46, 1553, 10.1016/j.jacc.2005.06.067

McCrohon, 2003, Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation, 108, 54, 10.1161/01.CIR.0000078641.19365.4C

Sparrow, 2006, Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study, AJR Am J Roentgenol, 187, W630, 10.2214/AJR.05.1264

Whittaker, 1994, Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light, Basic Res Cardiol, 89, 397, 10.1007/BF00788278

Nigri, 2009, Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology, Am Heart J, 157, 361, 10.1016/j.ahj.2008.09.012

Fielitz, 2001, Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease, J Am Coll Cardiol, 37, 1443, 10.1016/S0735-1097(01)01170-6

Fielitz, 2002, Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure, Circulation, 105, 286, 10.1161/hc0302.103593

Debl, 2006, Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis, Heart, 92, 1447, 10.1136/hrt.2005.079392

Weidemann, 2009, Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis, Circulation, 120, 577, 10.1161/CIRCULATIONAHA.108.847772

Assomull, 2006, Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy, J Am Coll Cardiol, 48, 1977, 10.1016/j.jacc.2006.07.049

Wu, 2008, Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy, J Am Coll Cardiol, 51, 2414, 10.1016/j.jacc.2008.03.018

Iles, 2008, Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping, J Am Coll Cardiol, 52, 1574, 10.1016/j.jacc.2008.06.049

Khan, 2000, Regression of hypertrophy after Carpentier-Edwards pericardial aortic valve replacement, Ann Thorac Surg, 69, 531, 10.1016/S0003-4975(99)01389-2

Lamb, 2002, Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation, J Am Coll Cardiol, 40, 2182, 10.1016/S0735-1097(02)02604-9

Carabello, 2002, Clinical practice, N Engl J Med, 346, 677, 10.1056/NEJMcp010846

Edwards, 2001, Prediction of operative mortality after valve replacement surgery, J Am Coll Cardiol, 37, 885, 10.1016/S0735-1097(00)01202-X

Kvidal, 2000, Observed and relative survival after aortic valve replacement, J Am Coll Cardiol, 35, 747, 10.1016/S0735-1097(99)00584-7

Jamieson, 1999, Risk stratification for cardiac valve replacement, Ann Thorac Surg, 67, 943, 10.1016/S0003-4975(99)00175-7

Chaliki, 2002, Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function, Circulation, 106, 2687, 10.1161/01.CIR.0000038498.59829.38